Cargando…
Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
The whole outcome for patients with gastric carcinoma (GC) is very poor because most of them remain metastatic disease during survival even at diagnosis or after surgery. Despite many improvements in multiple strategies of chemotherapy, immunotherapy, and targeted therapy, exploration of novel alter...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463074/ https://www.ncbi.nlm.nih.gov/pubmed/28544785 http://dx.doi.org/10.1002/cam4.1085 |